← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:1338 | 1338 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Povidone-Iodine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1338 | 1338 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1338 | 1338 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-605 | 81375-605-04 | Semaglutide | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1338 | 1338 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-3 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1338 | 1338 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2590 | 72934-2590-2 | Spironolactone; Dapsone; Niacinamide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1338 | 1338 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-029 | 70713-029-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1338 | 1338 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-005 | 70713-005-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1339 | 1339 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-887 | 69194-887-01 | 887 PITT KETAMINE 2.5 MG/ML SYRINGE | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1339 | 1339 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8069 | 71285-8069-1 | Oxytocin | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1476 | 5446-1476-01 | Phenol | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-024 | 71506-024-58 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1339 | 1339 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6045 | 71285-6045-1 | Oxytocin | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1342 | 72934-1342-2 | Salicylic Acid; Tretinoin; Imiquimod | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-9 | Rocuronium Bromide | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1339 | 1339 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Povidone-Iodine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-002 | 81375-002-05 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-601 | 81375-601-01 | Semaglutide | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-9 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1339 | 1339 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-045 | 70713-045-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1339 | 1339 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-032 | 70713-032-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1340 | 1340 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-294 | 70092-294-74 | Hydromorph PF 1 mg/ml 50ml NS CADD FSFF | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1340 | 1340 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1340 | 1340 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1340 | 1340 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenoxybenzamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9011 | 71266-9011-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1340 | 1340 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-084 | 70004-084-46 | Oxytocin | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6010 | 72196-6010-1 | Rocuronium Bromide | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6017 | 26436-6017-1 | Prasterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9055 | 83826-9055-4 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0049 | 81483-0049-4 | Semaglutide | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1340 | 1340 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1340 | 1340 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-004 | 70713-004-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1340 | 1340 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-038 | 70713-038-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1341 | 1341 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-91 | Azithromycin 500mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1341 | 1341 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1341 | 1341 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenoxybenzamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1652 | 5446-1652-01 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1341 | 1341 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-121 | 73702-121-06 | Oxytocin | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0418 | 72196-0418-1 | Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-850 | 70004-850-09 | Rocuronium Bromide | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0630 | 70168-0630-1 | Prasterone; Testosterone Cypionate | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1341 | 1341 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Semaglutide | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9684 | 71266-9684-5 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1341 | 1341 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-003 | 70713-003-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1341 | 1341 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-023 | 70713-023-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1342 | 1342 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-05 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1342 | 1342 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0550 | 71283-0550-2 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1342 | 1342 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1342 | 1342 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1342 | 1342 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2312 | 72627-2312-1 | Sermorelin Acetate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-124 | 71449-124-91 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-041 | 79926-041-01 | Prednisolone Acetate | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1342 | 1342 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1342 | 1342 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Semaglutide | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-086 | 70092-086-44 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1342 | 1342 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-040 | 70713-040-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1342 | 1342 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-045 | 70713-045-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1343 | 1343 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Trophamine 3.5%/Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1343 | 1343 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1343 | 1343 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6058 | 71285-6058-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6044 | 71285-6044-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-120 | 73702-120-05 | Oxytocin | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2314 | 72627-2314-1 | Sermorelin Acetate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-124 | 71449-124-83 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-040 | 79926-040-01 | Prednisolone Acetate | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1343 | 1343 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 84139-225 | 84139-225-01 | Semaglutide | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-034 | 71506-034-05 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1343 | 1343 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-005 | 70713-005-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1343 | 1343 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5109 | 26436-5109-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1344 | 1344 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1344 | 1344 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0903 | 60652-0903-1 | Oxytocin | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1344 | 1344 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7025 | 71285-7025-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8069 | 71285-8069-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1344 | 1344 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2313 | 72627-2313-1 | Sermorelin Acetate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-128 | 73702-128-95 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1344 | 1344 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1344 | 1344 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Ketorolac Tromethamine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0432 | 71285-0432-1 | Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-7536 | 60652-7536-1 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-3 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-032 | 70713-032-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1344 | 1344 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6023 | 26436-6023-3 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1345 | 1345 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-002 | 67157-002-15 | Alpha Lipoic Acid | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1345 | 1345 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5125 | 26436-5125-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1345 | 1345 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1345 | 1345 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6043 | 71285-6043-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1345 | 1345 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-55 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1345 | 1345 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1345 | 1345 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Ketorolac Tromethamine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0418 | 72196-0418-1 | Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-087 | 70092-087-46 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-9 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-038 | 70713-038-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1345 | 1345 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1375 | 73271-1375-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1346 | 1346 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-100 | 82396-100-10 | Sodium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1346 | 1346 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5326 | 26436-5326-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1346 | 1346 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1346 | 1346 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6045 | 71285-6045-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1346 | 1346 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1346 | 1346 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-59 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-002 | 81375-002-05 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5424 | 26436-5424-1 | Sermorelin Acetate | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-336 | 70092-336-46 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-8 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-023 | 70713-023-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1346 | 1346 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1050 | 73271-1050-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1347 | 1347 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9130 | 71266-9130-1 | Ropivacaine | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1347 | 1347 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-1 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1347 | 1347 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6092 | 72196-6092-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1347 | 1347 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1347 | 1347 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5592 | 26436-5592-1 | Sildenafil Citrate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-57 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1347 | 1347 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-200 | 81375-200-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5607 | 26436-5607-9 | Sermorelin Acetate | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6011 | 72196-6011-2 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1375 | 73271-1375-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1347 | 1347 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1875 | 73271-1875-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1348 | 1348 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1348 | 1348 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1348 | 1348 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6058 | 72196-6058-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5177 | 26436-5177-2 | Papaverine Hydrobromide; Phentolamine Mesylate; Alprostadil | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5591 | 26436-5591-1 | Sildenafil Citrate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-588 | 70092-588-38 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1348 | 1348 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Gatifloxacin | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1348 | 1348 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1348 | 1348 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1348 | 1348 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1348 | 1348 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1050 | 73271-1050-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1348 | 1348 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1200 | 73271-1200-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1349 | 1349 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6631 | 71300-6631-1 | Dexamethasone sodium phosphate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1349 | 1349 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2500 | 72627-2500-3 | Papaverine Hydrochloride; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1349 | 1349 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7025 | 72196-7025-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5100 | 71266-5100-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5508 | 26436-5508-1 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8075 | 71285-8075-1 | Sodium Acetate Anhydrous | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1370 | 61141-1370-5 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1349 | 1349 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Ketorolac Tromethamine; Gatifloxacin | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-08 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9995 | 51754-9995-1 | Sodium Acetate | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-03 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1349 | 1349 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1875 | 73271-1875-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1349 | 1349 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1125 | 73271-1125-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1350 | 1350 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-112 | 73177-112-03 | Phenylephrine | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1350 | 1350 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2501 | 72627-2501-3 | Papaverine Hydrochloride; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1350 | 1350 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1350 | 1350 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1350 | 1350 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5155 | 26436-5155-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8075 | 71285-8075-2 | Sodium Acetate Anhydrous | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1350 | 1350 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-200 | 81375-200-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1350 | 1350 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Bicarbonate | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-02 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1200 | 73271-1200-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1350 | 1350 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1100 | 73271-1100-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1351 | 1351 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-16 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-09-18 |